Lee Chien-Hung, Wu Deng-Chyang, Wu I-Chen, Goan Yih-Gang, Lee Jang-Ming, Chou Shah-Hwa, Chan Te-Fu, Huang Hsiao-Ling, Hung Yu-Hsiu, Huang Meng-Chuan, Lai Tai-Cheng, Wang Tsu-Nai, Lan Cheng-Che E, Tsai Sharon, Lin Wen-Yi, Wu Ming-Tsang
Department of Public Health, Kaohsiung Medical University, Taiwan.
Int J Cancer. 2009 Sep 1;125(5):1134-42. doi: 10.1002/ijc.24357.
Genetic variants in alcohol dehydrogenase-1B (ADH1B) and aldehyde dehydrogenase-2 (ALDH2) genes modulate acetaldehyde removal upon alcohol ingestion. Although these genetic vulnerabilities have been linked to higher esophageal squamous cell carcinoma (ESCC) risks, it is unclear whether they also determine the time of malignancy presentation. The purpose of this investigation was to unravel genotoxic effects of the two alcohol-metabolizing genes with regard to alcohol and tobacco consumption on the age at ESCC diagnosis and tumor dissemination. ADH1B/ALDH2 genotyping was performed on lymphocyte DNA specimens taken from 406 consecutively registered incident patients with pathology-proven ESCC. To fully utilize individual genetic and survival information, survival analyses and gene-longevity applied approaches were introduced. Among heavy drinkers, the ADH1B Arg/Arg (55 years) and ALDH2 Glu/Lys genotypes (54 years) were found to confer a 15 and 16 years earlier carcinoma diagnosed age than His/His and Glu/Glu nondrinkers (both 70 years), respectively. For drinkers, 1-year age advancement was, separately, associated with a 0.977 and 0.953-fold stepwise reduced likelihood of being ADH1B Arg homozygote and ALDH2 Lys variant. Noticeably elevated hazard-ratio (HR) for drinkers of ADH1B slow-form genotype and ALDH2 inactive-form allele were identified in smokers (HR = 2.3-2.6), but no in nonsmokers. In smokers, appreciably higher cumulative cancer onset risks were correspondingly recognized from the age of 45 and 49 upward among any + Lys allele and Arg/Arg + Glu/Glu combined-ADH1B/ALDH2-genotype drinkers than nondrinkers. In conclusion, consumption of tobacco and alcohol, coupled with genetic susceptibilities associated with acetaldehyde elimination, as modulated by ADH1B and ALDH2 genotypes, determines a substantial magnitude of tumorigenetic effect on earlier age ESCC diagnosis.
乙醇脱氢酶-1B(ADH1B)和乙醛脱氢酶-2(ALDH2)基因中的遗传变异可调节饮酒后乙醛的清除。尽管这些遗传易感性与较高的食管鳞状细胞癌(ESCC)风险相关,但尚不清楚它们是否也决定恶性肿瘤出现的时间。本研究的目的是揭示这两个酒精代谢基因在酒精和烟草消费方面对ESCC诊断年龄和肿瘤扩散的遗传毒性作用。对406例经病理证实的ESCC连续登记的初发患者的淋巴细胞DNA样本进行了ADH1B/ALDH2基因分型。为了充分利用个体遗传和生存信息,引入了生存分析和基因寿命应用方法。在重度饮酒者中,发现ADH1B基因的Arg/Arg基因型(55岁)和ALDH2基因的Glu/Lys基因型(�4岁)分别比His/His和Glu/Glu非饮酒者(均为70岁)的癌症诊断年龄提前15年和16年。对于饮酒者,年龄每增加1岁,分别与ADH1B基因Arg纯合子和ALDH2基因Lys变异体的可能性逐步降低0.977倍和0.953倍相关。在吸烟者中,发现ADH1B慢型基因型和ALDH2无活性型等位基因饮酒者的风险比(HR)明显升高(HR = 2.3-2.6),但在不吸烟者中未发现。在吸烟者中,任何+Lys等位基因和Arg/Arg + Glu/Glu联合ADH1B/ALDH2基因型饮酒者从45岁和49岁起的累积癌症发病风险相应地明显高于非饮酒者。总之,烟草和酒精的消费,加上由ADH1B和ALDH2基因型调节的与乙醛消除相关的遗传易感性,决定了对ESCC早期诊断的肿瘤发生效应的相当大程度。